157 related articles for article (PubMed ID: 3019224)
1. Regression of rat mammary tumors associated with suppressed growth hormone.
Phares CK
Anticancer Res; 1986; 6(4):845-8. PubMed ID: 3019224
[TBL] [Abstract][Full Text] [Related]
2. Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
Rose DP; Noonan JJ
Cancer Res; 1982 Jan; 42(1):35-8. PubMed ID: 6797725
[TBL] [Abstract][Full Text] [Related]
3. Hormonal induction of casein gene expression limited to a small subpopulation of 7,12-dimethylbenz(a)anthracene-induced mammary tumor cells.
Supowit SC; Rosen JM
Cancer Res; 1982 Apr; 42(4):1355-60. PubMed ID: 6800652
[TBL] [Abstract][Full Text] [Related]
4. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
Gandilhon P; Mélançon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
[TBL] [Abstract][Full Text] [Related]
5. Some biochemical effects of the growth hormone analogue produced by plerocercoids of the tapeworm Spirometra mansonoides on carbohydrate metabolism of adipose tissue from normal, diabetic, and hypophysectomized rats.
Salem MA; Phares CK
J Parasitol; 1986 Aug; 72(4):498-506. PubMed ID: 3537254
[TBL] [Abstract][Full Text] [Related]
6. Influence of thyroidectomy and prolactin suppression on the growth of N-nitrosomethylurea-induced rat mammary carcinomas.
Rose DP; Mountjoy KG
Cancer Res; 1983 Jun; 43(6):2588-91. PubMed ID: 6850579
[TBL] [Abstract][Full Text] [Related]
7. Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
Manni A; Rainieri J; Arafah BM; Finegan HM; Pearson OH
Cancer Res; 1982 Sep; 42(9):3492-5. PubMed ID: 6286107
[TBL] [Abstract][Full Text] [Related]
8. Reduction of lactogenic receptors in female hamster liver due to the human growth hormone analog produced by plerocercoids of the tapeworm, Spirometra mansonoides.
Phares CK; Booth BJ
Endocrinology; 1986 Mar; 118(3):1102-9. PubMed ID: 3004894
[TBL] [Abstract][Full Text] [Related]
9. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
[TBL] [Abstract][Full Text] [Related]
10. Hormone dependence of 7,12-dimethylbenz[a]anthracene-induced mammary tumor growth: correlation with prostaglandin E2 content.
Foecking MK; Kibbey WE; Abou-Issa H; Matthews RH; Minton JP
J Natl Cancer Inst; 1982 Aug; 69(2):443-6. PubMed ID: 6810004
[TBL] [Abstract][Full Text] [Related]
11. An expression study of hormone receptors in spontaneously developed, carcinogen-induced and hormone-induced mammary tumors in female Noble rats.
Cheung SY; Yuen MT; Choi HL; Cheng HK; Huang Y; Chen S; Chan FL
Int J Oncol; 2003 Jun; 22(6):1383-95. PubMed ID: 12739009
[TBL] [Abstract][Full Text] [Related]
12. N-methyl-N-nitrosourea-induced rat mammary tumors. Hormone responsiveness but lack of spontaneous metastasis.
Williams JC; Gusterson B; Humphreys J; Monaghan P; Coombes RC; Rudland P; Neville AM
J Natl Cancer Inst; 1981 Jan; 66(1):147-55. PubMed ID: 6779042
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ovariectomy and retinyl acetate on the growth of established 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat.
Gandilhon P; Melancon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1982 Aug; 69(2):447-51. PubMed ID: 6287078
[TBL] [Abstract][Full Text] [Related]
14. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
Tamarkin L; Cohen M; Roselle D; Reichert C; Lippman M; Chabner B
Cancer Res; 1981 Nov; 41(11 Pt 1):4432-6. PubMed ID: 6796259
[TBL] [Abstract][Full Text] [Related]
15. Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract.
Freudenstein J; Dasenbrock C; Nisslein T
Cancer Res; 2002 Jun; 62(12):3448-52. PubMed ID: 12067987
[TBL] [Abstract][Full Text] [Related]
16. Rat mammary carcinoma regressions during suppression of serum growth hormone and prolactin.
Rose DP; Gottardis M; Noonan JJ
Anticancer Res; 1983; 3(5):323-5. PubMed ID: 6139974
[TBL] [Abstract][Full Text] [Related]
17. Suppression of receptors for prolactin and estrogen in rat liver due to treatment with the growth hormone analogue produced by the tapeworm Spirometra mansonoides.
Phares CK; Booth BJ
J Recept Res; 1986; 6(5-6):425-46. PubMed ID: 3585861
[TBL] [Abstract][Full Text] [Related]
18. Characterization of estradiol, progesterone, and prolactin receptors in nitrosomethylurea-induced mammary tumors and effect of antiestrogen treatment on the development and growth of these tumors.
Turcot-Lemay L; Kelly PA
Cancer Res; 1980 Sep; 40(9):3232-40. PubMed ID: 6253058
[No Abstract] [Full Text] [Related]
19. Interactions between estrogens, prolactin, and growth hormone on the growth of N-nitrosomethylurea-induced rat mammary tumors.
Rose DP; Gottardis M
Anticancer Res; 1985; 5(4):397-402. PubMed ID: 4037735
[TBL] [Abstract][Full Text] [Related]
20. Effects of isoproterenol on mammary gland tumors induced by N-nitroso-N-methylurea and salivary gland tumors induced by 7,12-dimethylbenz[a]anthracene.
Barka T
J Natl Cancer Inst; 1982 Nov; 69(5):1115-20. PubMed ID: 6813551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
